Nearly three months ago Medtronic (Minneapolis) presented data at the 69th annual American Diabetes Association (ADA; Alexandria, Vriginia) touting the development of a new platform that could automatically monitor and deliver insulin to patients based on their physiological reactions to environment and activity (Medical Device Daily, June 10, 2009). The med-tech giant said that the release of such a platform was on the horizon. (Medical Device Daily)

PLC Medical Systems (Franklin, Massachusetts) reported that the initial abstract results from a clinical study evaluating the effectiveness of its RenalGuard System have been published. The company said that the investigator-sponsored clinical study has also been published on the European Society of Cardiology (Sophia Antipolis, France) web site in advance of that society's annual meeting Aug. 29 Sept. 2, 2009 in Barcelona, Spain. (Medical Device Daily)

Usually wound therapies are treatments that include some sort of external component to help a patient heal. Sanuwave (Alpharetta, Georgia), a developer of noninvasive, biologic response activating devices in the regenerative medicine segment, is looking at going against conventional woundcare therapy logic and has developed an application that will stimulate the body's own natural ability to heal. (Medical Device Daily)

Taxing job-based health benefits would adversely affect low income families, according to a new study completed by two Harvard researchers. (Medical Device Daily)